ContextVision Sees Strongest Quarter Ever with Record Sales and Product Momentum within Digital Pathology
STOCKHOLM – April 23, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced record sales and EBITDA, mainly driven by the company’s medical imaging business, despite the current global challenges. ContextVision’s first digital pathology solution continues to accelerate toward market availability. Medical ImagingSales in Q1 ended at 29.2 MSEK, a substantial increase of 38.4% compared to the first quarter in 2019. EBITDA was 13,8 MSEK and the operating result ended at 11,8 MSEK, strengthening the liquidity